Long COVID and Cognitive Dysfunction: Searching for Answers
Gilbert H. Glaser professor of Neurology and chief of the Division of Neurological Infections and Global Neurology Serena Spudich, MD shares her knowledge of cognitive dysfunction in long-COVID patients, research conducted in her COVID Mind Study and Yale program, and what treatment options are currently available.Source: TheBodyPro
Natalia Szejko, MD, PhD Wins 2022 ESOC Young Research Investigator Award for Stroke Research
During the 2022 European Stroke Organisation Conference (ESOC) held from May 4-6, Natalia Szejko, MD, PhD a postdoctoral fellow in the Falcone Lab was awarded the ESOC Young Research Investigator Award in Stroke for her submitted abstract, “Epigenetic Age and Ischemic Stroke: Findings from the Health and Retirement Study.”
Philanthropist Nancy Davis Opens Up About Life with Multiple Sclerosis and Her Mission to Help Others
Philanthropist Nancy Davis tells her story of living with multiple sclerosis, from her diagnosis after a ski accident to how she eventually found the treatment plan that was right for her. Yale Neurology Chair David Hafler, MD also speaks about how far research into the autoimmune disease has come and what the most effective treatment strategies are.Source: People
Four Yale Researchers Honored at the 2022 Association for Clinical and Translational Science Awards
The collaboration that advanced the discovery of ketamine as a treatment for depression was among four Yale award winners at the Association for Clinical and Translational Science (ACTS) annual meeting held in Chicago from April 20 through 22.
How Effects on the Brain Can Produce Long COVID
COVID-19 may be primarily a respiratory illness, but its reach extends far beyond the lungs, with an impact that includes the brain. The neurologic and psychiatric complications of COVID-19 are incredibly diverse and sometimes persist long after patients recover from their initial infections.
Portable MRIs Almost as Effective as Standard MRIs in Detecting Strokes
“This is the first systematic evidence you can detect ischemic strokes using portable, bedside devices,” said Kevin Sheth, a professor of neurology and neurosurgery at Yale School of Medicine and co-corresponding author of the study.Source: YaleNews
Emily Gilmore, MD Joins the American Board of Clinical Neurophysiology
The American Board of Clinical Neurophysiology (ABCN) has invited associate professor Emily Gilmore, MD, to serve as board member, effective immediately. Dr. Gilmore will play a significant role in the ABCN examination development, including writing and editing questions.
Revealing Communications Between Brain and Body
“This is the first time we actually know how different body signals are being represented through the vagal interoception system to the brain in a very precise and accurate manner,” says co-senior investigator Rui Chang, PhD. “We know that the brain can very precisely discriminate signals, but what is the biological reason for that discrimination?”
Gianvito Masi, MD Named MGNet Scholar for Myasthenia Gravis Research
Gianvito Masi, MD, a neurologist in the lab of Kevin O’Connor, PhD, has been selected as a MGNet Scholar by the Myasthenia Gravis Rare Disease Network (MGNet), which is part of the National Institutes of Health’s Rare Diseases Clinical Research Network. The grant, “Investigating immune mechanisms underlying checkpoint inhibitor myasthenia gravis,” funds two years of research and will begin in June 2022.
Yale experts make strides in Multiple Sclerosis research
Yale School of Medicine researchers have furthered our understanding of the immune mechanisms of multiple sclerosis, discovered that B-cell depleting drugs reduce symptoms of inflammation in MS patients, and have made significant strides in earlier diagnoses.Source: Yale Daily News
The Migraine Breakthrough
Regarded as a game-changer in migraine treatment, researchers discovered that migraines are caused by activated fibers in the trigeminal nerve and the subsequent blood vessel dilation in the meninges. Monoclonal antibodies have been shown to block the chemical signal that causes this phenomenon, thereby greatly reducing the frequency and severity of migraine.Source: Connecticut Health I-Team
Yale Researchers Conduct Trial Using Ketamine to Treat Depression in People with Parkinson’s
Sophie Holmes, PhD, assistant professor of psychiatry, and Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, spoke to WTNH - News 8 about their clinical trials that use the anesthetic ketamine to treat depression in people with Parkinson's disease.Source: WTNH - News 8